Zajicek, J and Fox, P and Sanders, H and Wright, D and Vickery, J and Nunn, A and Thompson, A and UK MS Research Group, (2003) Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet , 362 (9395) 1517 - 1526. 10.1016/S0140-6736(03)14738-1.
Full text not available from this repository.
Multiple sclerosis is associated with muscle stiffness, spasms, pain, and tremor. Much anecdotal evidence suggests that cannabinoids could help these symptoms. Our aim was to test the notion that cannabinoids have a beneficial effect on spasticity and other symptoms related to multiple sclerosis.
|Title:||Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.|
|Keywords:||Cannabidiol, Cannabinoids, Female, Great Britain, Humans, Locomotion, Male, Middle Aged, Multiple Sclerosis, Muscle Spasticity, Outcome Assessment (Health Care), Physical Examination, Placebos, Recurrence, Tetrahydrocannabinol, Treatment Outcome, Walking|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Brain Sciences|
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health Care > Infection and Population Health
Archive Staff Only: edit this record